Intensive Care Unit (ICU) Acquired Weakness (ICU - AW), Muscle Weakness
Conditions
Brief summary
Little is known about nutritional Parameters that potentially influence the course of intensive-care unit acquired weakness (ICU - AW). The investigators aim to elucidate the nutritional profiles in blood, urine and muscle in respective patients at risk.
Interventions
None listed
Sponsors
Nestec Ltd.
Insel Gruppe AG, University Hospital Bern
Study design
Observational model
OTHER
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Age ≥18 years * Written informed consent obtained from the patient's legal representative and later from the patients (as soon as possible) * Individuals diagnosed with severe head trauma or intracerebral hemorrhage (central nervous system group) or with severe sepsis/ septic shock (Sepsis group) at any time from ICU admission until day 5 (i.e. day of screening) * Patient on the ICU for ≥ 5 days (ICU long stayer)
Exclusion criteria
* Language other than German or French * Institutionalized Individuals (e.g. prisoners, severe pre-existing mental incapacity) * Patients with known pre-existing neurological or psychiatric disease that will make informed consent likely impossible * Patients with known pregnancy or known to be lactating will not be included to the investigation. Due to the observational/ diagnostical nature of the study, a pregnancy test will not be performed. * Patients on extracorporeal membrane oxygenation (ECMO) * Clinical signs of pre-existing malnutrition (Body mass index \<18) * Pre-existing evidence for history of anorexia or bulimia * Parenteral nutrition received within last 5 days (for more than 12 hours) or evidence for parental nutrition needed within next 7 days * Terminal disease (i.e. life expectancy \<14 days) * Patients with active malignancy * Patients on biologicals interfering with metabolism (e.g. infliximab) * Patients on chronic steroid medication (i.e. prednisone equivalent dose \>10mg/day) * Patients on neuromuscular blocking agents on a regular basis (i.e. on a repetitive basis within last 48 hours or evidence for need within next 7 days) * At screening (day 5): prescribed caloric intake substantially higher (i.e. \> 150% of caloric need of indirect calorimetry) than indirect calorimetric results (in intubated patients) or i.e. standard-of-care (25 Kcal/kg body weight/day) * Severe adipositas defined as BMI \>40 * Known pre-existing allergy to standard enteral formulae * Subject previously enrolled to an interventional trial that is not considered standard-of-care (e.g. investigation of new medication/drug or medical devices)
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Differences in blood nutrient levels over time in patients with/without ICU-AW (i.e. ICU-AW group vs. no-ICU-AW group. Primary comparison of interest is between day 14 vs. day 6. | days 6 to 14 |
| Differences in blood nutrient levels over time in patients in sepsis group vs. CNS group. Primary comparison of interest is between day 14 vs. day 6. | days 6 to 14 |
Secondary
| Measure | Time frame |
|---|---|
| Differences in urine nutrient levels over time in patients with/ without ICU-AW (i.e. ICU-AW group vs. no-ICU-AW group. Primary comparison of interest is between day 14 vs. day 6. | days 6 to 14 |
| Differences in urine nutrient levels over time in patients in sepsis group vs. CNS group. Primary comparison of interest is between day 14 vs. day 6. | days 6 to 14 |
| Subgroup analysis: differences in nutrient levels at day 14 vs. day 6 in muscle biopsy samples of ICU long stayer patients in study groups (i.e. ICU-AW vs. no-ICU-AW and Sepsis vs. CNS). | days 6 to 14 |
Countries
Switzerland
Outcome results
None listed